# Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. – FDA Inspection, Sep 10, 2019

Source: https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/fffa5f62-5ff7-461b-9118-e485bdad04e8
Source feed: FDA_Inspections

> FDA inspection 1106423 of Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd., September 10, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106423
- Company Name: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Inspection Date: 2019-09-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1230640 - 2024-03-22](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/ea9811aa-4107-436d-8e97-c772f1bed4ec)
- [FDA Inspection 1049653 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/1ea9dae0-e4fd-4cb3-a59d-f9b811fe8d21)
- FDA Inspection 958528 - 2016-02-12
- FDA Inspection 888415 - 2014-06-26
- FDA Inspection 801261 - 2012-07-09

## Related Officers

- [Constantin Y. Philopoulos](https://www.keypedia.com/people/constantin-y-philopoulos/536d53f5-7699-4b27-8b4b-10280cce9603)

Company: https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c